Dermata Therapeutics (DRMA) Institutional Ownership $1.27 -0.06 (-4.51%) As of 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Dermata Therapeutics (NASDAQ:DRMA)CurrentInstitutional OwnershipPercentage8.67%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$2.06MNumber ofInstitutional Sellers(last 12 months)0 Get DRMA Insider Trade Alerts Want to know when executives and insiders are buying or selling Dermata Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data DRMA Institutional Buying and Selling by Quarter Dermata Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024Armistice Capital LLC28,000$67K0.0%N/A4.982% 2/13/2024Armistice Capital LLC218,000$133K0.0%N/A6.158% 11/13/2023Acadian Asset Management LLC75,538$79K0.0%+34.2%2.368% 8/7/2023Acadian Asset Management LLC56,285$92K0.0%N/A2.405% 7/27/2023Virtu Financial LLC32,105$53K0.0%N/A1.372% 11/7/2022Virtu Financial LLC70,808$37K0.0%N/A0.701% (Data available from 1/1/2016 forward) DRMA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DRMA shares? During the previous two years, the following institutional investors and hedge funds held shares of Dermata Therapeutics shares: Acadian Asset Management LLC ($79K), and Armistice Capital LLC ($67K), Virtu Financial LLC ($53K).Learn more on DRMA's institutional investors. What percentage of Dermata Therapeutics stock is owned by institutional investors? 8.67% of Dermata Therapeutics stock is owned by institutional investors. Learn more on DRMA's institutional investor holdings. Which institutional investors have been buying Dermata Therapeutics stock? The following institutional investors have purchased Dermata Therapeutics stock in the last 24 months: Armistice Capital LLC ($246K), Acadian Asset Management LLC ($75.54K), and Virtu Financial LLC ($32.11K). How much institutional buying is happening at Dermata Therapeutics? Institutional investors have bought a total of 353,643 shares in the last 24 months. This purchase volume represents approximately $4.56M in transactions. Related Companies TSBX Institutional Ownership BLRX Institutional Ownership JAGX Institutional Ownership MBIO Institutional Ownership EYEN Institutional Ownership AWH Institutional Ownership PMCB Institutional Ownership AYTU Institutional Ownership KPRX Institutional Ownership TLPH Institutional Ownership This page (NASDAQ:DRMA) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dermata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dermata Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DRMA Stock Alerts